69 related articles for article (PubMed ID: 17850390)
1. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
[TBL] [Abstract][Full Text] [Related]
2. Orthotopic Mouse Models of Urinary Bladder Cancer.
Noh JI; Ahn EJ; Noh MG; Moon KS; Chung E; Choi C; Lee KH; Kim SS
In Vivo; 2023; 37(5):2039-2043. PubMed ID: 37652486
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.
Ramasawmy R; Johnson SP; Roberts TA; Stuckey DJ; David AL; Pedley RB; Lythgoe MF; Siow B; Walker-Samuel S
PLoS One; 2016; 11(5):e0156162. PubMed ID: 27223614
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models.
Haider MT; Freytag V; Krause L; Spethmann T; Gosau T; Beine MC; Knies C; Schröder-Schwarz J; Horn M; Riecken K; Lange T
Clin Exp Metastasis; 2024 Apr; 41(2):103-115. PubMed ID: 38353934
[TBL] [Abstract][Full Text] [Related]
5. Validation of a combined ultrasound and bioluminescence imaging system with magnetic resonance imaging in orthotopic pancreatic murine tumors.
Rojas JD; Joiner JB; Velasco B; Bautista KJB; Aji AM; Moore CJ; Beaumont NJ; Pylayeva-Gupta Y; Dayton PA; Gessner RC; Czernuszewicz TJ
Sci Rep; 2022 Jan; 12(1):102. PubMed ID: 34996939
[TBL] [Abstract][Full Text] [Related]
6. Development of orthotopic tumour models using ultrasound-guided intrahepatic injection.
McVeigh LE; Wijetunga I; Ingram N; Marston G; Prasad R; Markham AF; Coletta PL
Sci Rep; 2019 Jul; 9(1):9904. PubMed ID: 31289364
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of human bladder cancer as a tool for drug discovery.
Seager C; Puzio-Kuter AM; Cordon-Cardo C; McKiernan J; Abate-Shen C
Curr Protoc Pharmacol; 2010 Jun; Chapter 14():Unit14.14. PubMed ID: 22294368
[TBL] [Abstract][Full Text] [Related]
8. Urease-powered nanobots for radionuclide bladder cancer therapy.
Simó C; Serra-Casablancas M; Hortelao AC; Di Carlo V; Guallar-Garrido S; Plaza-García S; Rabanal RM; Ramos-Cabrer P; Yagüe B; Aguado L; Bardia L; Tosi S; Gómez-Vallejo V; Martín A; Patiño T; Julián E; Colombelli J; Llop J; Sánchez S
Nat Nanotechnol; 2024 Apr; 19(4):554-564. PubMed ID: 38225356
[TBL] [Abstract][Full Text] [Related]
9. Fast Ultrasound Scanning is a Rapid, Sensitive, Precise and Cost-Effective Method to Monitor Tumor Grafts in Mice.
Molière S; Martinet A; Jaulin A; Lodi M; Chamaraux-Tran TN; Alpy F; Bierry G; Tomasetto C
J Mammary Gland Biol Neoplasia; 2024 Jan; 29(1):2. PubMed ID: 38289494
[TBL] [Abstract][Full Text] [Related]
10. Validation of Dual Energy X-ray Absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma.
Sechrist ZR; Lee G; Schwarz EM; Cole CL
bioRxiv; 2023 Sep; ():. PubMed ID: 37790492
[TBL] [Abstract][Full Text] [Related]
11. Mouse orthotopic models for bladder cancer research.
Chan E; Patel A; Heston W; Larchian W
BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981
[TBL] [Abstract][Full Text] [Related]
12. Bone Metastasis in Bladder Cancer.
Yi L; Ai K; Li X; Li Z; Li Y
J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675715
[TBL] [Abstract][Full Text] [Related]
13. Novel catheter design enables transurethral catheterization of male mice.
Lamanna OK; Hsieh MH; Forster CS
Am J Physiol Renal Physiol; 2020 Jul; 319(1):F29-F32. PubMed ID: 32463724
[TBL] [Abstract][Full Text] [Related]
14. Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma.
Sugase T; Lam BQ; Danielson M; Terai M; Aplin AE; Gutkind JS; Sato T
J Transl Med; 2020 May; 18(1):208. PubMed ID: 32434572
[TBL] [Abstract][Full Text] [Related]
15. Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.
Raven PA; D'Costa NM; Moskalev I; Tan Z; Frees S; Chavez-Munoz C; So AI
Am J Clin Exp Urol; 2018; 6(6):245-259. PubMed ID: 30697580
[TBL] [Abstract][Full Text] [Related]
16. A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis.
Gills J; Moret R; Zhang X; Nelson J; Maresh G; Hellmers L; Canter D; Hudson M; Halat S; Matrana M; Marino MP; Reiser J; Shuh M; Laborde E; Latsis M; Talwar S; Bardot S; Li L
Oncotarget; 2018 Aug; 9(66):32718-32729. PubMed ID: 30220977
[TBL] [Abstract][Full Text] [Related]
17. Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.
Frees S; Breuksch I; Haber T; Bauer HK; Chavez-Munoz C; Raven P; Moskalev I; D Costa N; Tan Z; Daugaard M; Thüroff JW; Haferkamp A; Prawitt D; So A; Brenner W
Oncotarget; 2018 Mar; 9(21):15766-15779. PubMed ID: 29644008
[TBL] [Abstract][Full Text] [Related]
18. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
Huebner D; Rieger C; Bergmann R; Ullrich M; Meister S; Toma M; Wiedemuth R; Temme A; Novotny V; Wirth MP; Bachmann M; Pietzsch J; Fuessel S
BMC Cancer; 2017 Nov; 17(1):790. PubMed ID: 29169339
[TBL] [Abstract][Full Text] [Related]
19. The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression.
Seo HK; Shin SP; Jung NR; Kwon WA; Jeong KC; Lee SJ
Oncotarget; 2017 Aug; 8(31):50500-50509. PubMed ID: 28881578
[TBL] [Abstract][Full Text] [Related]
20. Effect of contrast media on urinary cytopathology specimens.
Frees S; Bidnur S; Metcalfe M; Raven P; Chavez-Munoz C; Moskalev I; Fazli L; So A
Can Urol Assoc J; 2016 Aug; 10(7-8):228-233. PubMed ID: 27878040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
